Role of T cell costimulation in anti-viral immunity

Seminars in Immunology

Volumn 16, Issue 3, 2004, Pages 185-196

  Bertram, Edward M ^a   Dawicki, Wojciech ^b   Watts, Tania H ^b  

^a Australian National University   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CD28 family; Costimulation; DLN; draining lymph node; T cells; thymidine kinase; TIM; TK; TNF receptor associated factor; TNFR; TNFR family; TRAF; TRAF interacting motif; tumor necrosis factor receptor; Viruses

Indexed keywords

B7 ANTIGEN; CD134 ANTIGEN; CD137 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; IMMUNOGLOBULIN M; INDUCIBLE COSTIMULATOR PROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME INDUCTION; HELPER CELL; HERPES VIRUS; INFLUENZA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD70; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 2342631978     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2004.02.006     Document Type: Review

References (131)

1. Bachmann M.F., Zinkernagel R.M., Oxenius A. Immune responses in the absence of costimulation: viruses know the trick. J. Immunol. 161:1998;5791-5794
2. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Ann. Rev. Immunol. 14:1996;233-258
3. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:2002;116-126
4. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14:2003;265-273
5. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:2003;609-620
6. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:2002;29-53
7. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature. 409:2001;102-105
8. Tafuri A., Shahinian A., Bladt F., Boucher L.-M., Bouchard D., Chan V.S.F., et al. ICOS is essential for effective T-helper-cell responses. Nature. 409:2001;105-109
9. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-265
10. Dong C., Juedes A.E., Temann U.-A., Shresta S., Allison J.P., Ruddle N.H., et al. ICOS co-stimulatory receptor is essential for T cell activation and function. Nature. 409:2001;97-101
11. Dong C., Temann U.A., Flavell R.A. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166:2001;3659-3662
12. Mak T.W., Shahinian A., Yoshinaga S.K., Wakeham A., Boucher L.M., Pintilie M., et al. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4:2003;765-772
13. Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33:2003;3117-3126
14. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104:2001;487-501
15. Dempsey P.W., Doyle S.E., He J.Q., Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14:2003;193-209
16. Rudd C.E., Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3:2003;544-556
17. Harlin H., Podack E., Boothby M., Alegre M.L. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. J. Immunol. 169:2002;2451-2459
18. Tamada K., Ni J., Zhu G., Fiscella M., Teng B., Van Deursen J.M., et al. Cutting edge: selective impairment of CD8(+) T cell function in mice lacking the TNF superfamily member LIGHT. J. Immunol. 168:2002;4832-4835
19. Scheu S., Alferink J., Potzel T., Barchet W., Kalinke U., Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 195:2002;1613-1624
20. Granger S.W., Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev. 14:2003;289-296
21. Grewal I.S., Flavell R.A. CD40 and CD154 in cell-mediated immunity. Ann. Rev. Immunol. 16:1998;111-135
22. Josien R., Li H.L., Ingulli E., Sarma S., Wong B.R., Vologodskaia M., et al. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191:2000;495-502
23. Bachmann M.F., Wong B.R., Josien R., Steinman R.M., Oxenius A., Choi Y. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189:1999;1025-1031
24. Seko Y., Takahashi N., Oshima H., Shimozato O., Akiba H., Takeda K., et al. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackie virus B3. J. Pathol. 195:2001;593-603
25. Summers K.L., Hock B.D., McKenzie J.L., Hart D.N. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159:2001;285-295
26. Mak T.W., Penninger J.M., Ohashi P.S. Knockout mice: a paradigm shift in modern immunology. Nat. Rev. Immunol. 1:2001;11-19
27. Oldstone M.B. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263:2002;83-117
28. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R.M., et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:1995;3256-3262
29. Ciurea A., Klenerman P., Hunziker L., Horvath E., Odermatt B., Ochsenbein A.F., et al. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11964-11969
30. Wagner RR. The rhabdoviruses. New York: Plenum Press; 1987.
31. Bachmann M.F., Kundig T.M. In vivo versus in vitro assays for assessment of T- and B-cell function. Curr. Opin. Immunol. 6:1994;320-326
32. Woodland D.L., Randall T.D. Anatomical features of anti-viral immunity in the respitoratory tract. Sem Immunol. 16:2004;163-170
33. Brown D.M., Román E., Swain S.L. CD4 T cell responses to influenza infection. Sem Immunol. 16:2004;171-177
34. Doherty P.C., Christensen J.P. Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18:2000;561-592
35. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:1993;609-612
36. McAdam A.J., Farkash E.A., Gewurz B.E., Sharpe A.H. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J. Virol. 74:2000;203-208
37. Bertram E.M., Lau P., Watts T.H. Temporal segregation of CD28 versus 4-1BBL-mediated costimulation: 4-1BBL influences T cell numbers late in the primary response and regulates the size of the memory response following influenza infection. J. Immunol. 168:2002;3777-3785
38. Lee B.J., Reiter S.K., Anderson M., Sarawar S.R. CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68. J. Virol. 76:2002;3049-3053
39. Ferguson S.E., Han S., Kelsoe G., Thompson C.B. CD28 is required for germinal center formation. J. Immunol. 156:1996;4576-4581
40. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 6:1997;303-313
41. Kopf M., Coyle A.J., Schmitz N., Barner M., Oxenius A., Gallimore A., et al. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192:2000;53-61
42. Christensen J.E., Christensen J.P., Kristensen N.N., Hansen N.J., Stryhn A., Thomsen A.R. Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells. Int. Immunol. 14:2002;701-711
43. Edelmann K.H., Wilson C.B. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J. Virol. 75:2001;612-621
44. Kundig T.M., Shahinian A., Kawai K., Mittrucker H.W., Sebzda E., Bachmann M.F., et al. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity. 5:1996;41-52
45. Sigal L.J., Reiser H., Rock K.L. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161:1998;2740-2745
46. Suresh M., Whitmire J.K., Harrington L.E., Larsen C.P., Pearson T.C., Altman J.D., et al. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167:2001;5565-5573
47. Tan J.T., Whitmire J.K., Ahmed R., Pearson T.C., Larsen C.P. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163:1999;4859-4868
48. Wang B., Maile R., Greenwood R., Collins E.J., Frelinger J.A. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J. Immunol. 164:2000;1216-1222
49. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains [see comments]. Science. 283:1999;680-682
50. Saoulli K., Lee S.Y., Cannons J.L., Yeh W.C., Santana A., Goldstein M.D., et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187:1998;1849-1862
51. Kim S.K., Schluns K.S., Lefrancois L. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J. Immunol. 163:1999;4125-4132
52. Thebeau L.G., Morrison L.A. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation. J. Virol. 77:2003;2426-2435
53. Liu Y., Wenger R.H., Zhao M., Nielsen P.J. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185:1997;251-262
54. DeBenedette M.A., Wen T., Bachmann M.F., Ohashi P.S., Barber B.H., Stocking K.L., et al. Analysis of 4-1BB ligand-deficient mice and of mice lacking both 4-1BB ligand and CD28 reveals a role for 4-1BB ligand in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163:1999;4833-4841
55. Chen W., Bennink J.R., Morton P.A., Yewdell J.W. Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus. J. Virol. 76:2002;10332-10337
56. Lumsden J.M., Roberts J.M., Harris N.L., Peach R.J., Ronchese F. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J. Immunol. 164:2000;79-85
57. Halstead E.S., Mueller Y.M., Altman J.D., Katsikis P.D. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat. Immunol. 3:2002;536-541
58. Hendriks J., Xiao Y., Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T Cell pool. J. Exp. Med. 198:2003;1369-1380
59. Bertram E.M., Dawicki W., Sedgmen B., Bramson J.L., Lynch D.H., Watts T.H. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol. 172:2004;981-988
60. Chambers C.A., Sullivan T.J., Truong T., Allison J.P. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28:1998;3137-3143
61. Parry R.V., Rumbley C.A., Vandenberghe L.H., June C.H., Riley J.L. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J. Immunol. 171:2003;166-174
62. Bertram EM, Tafuri A, Shahinian A, Chan VS, Hunziker L, Rechner M, et al. Role of ICOS versus CD28 in anti-viral immunity. Eur J Immunol 2002;32:3376-85.
63. DeBenedette M.A., Shahinian A., Mak T.W., Watts T.H. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158:1997;551-559
64. Ohshima Y., Tanaka Y., Tozawa H., Takahashi Y., Maliszewski C., Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:1997;3838-3848
65. Murata K., Ishii N., Takano H., Miura S., Ndhlovu L.C., Nose M., et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191:2000;365-374
66. Futagawa T., Akiba H., Kodama T., Takeda K., Hosoda Y., Yagita H., et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14:2002;275-286
67. Diehl L., van Mierlo G.J., den Boer A.T., van der Voort E., Fransen M., van Bostelen L., et al. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol. 168:2002;3755-3762
68. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M., Schuurhuis D.H., Mebius R.E., et al. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170:2003;33-40
69. Grewal I.S., Borrow P., Pamer E.G., Oldstone M.B., Flavell R.A. The CD40-CD154 system in anti-infective host defense. Curr. Opin. Immunol. 9:1997;491-497
70. Borrow P., Tishon A., Lee S., Xu J., Grewal I.S., Oldstone M.B., et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183:1996;2129-2142
71. Lee B.O., Hartson L., Randall T.D. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J. Exp. Med. 198:2003;1759-1764
72. Andreasen S.O., Christensen J.E., Marker O., Thomsen A.R. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J. Immunol. 164:2000;3689-3697
73. Lens S.M., Tesselaar K., van Oers M.H., van Lier R.A. Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol. 10:1998;491-499
74. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat. Immunol. 4:2003;49-54
75. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A.W., Schumacher T.N.M., Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:2000;433-440
76. Vinay D.S., Kwon B.S. Role of 4-1BB in immune responses. Sem. Immunol. 10:1998;481-489
77. Wilcox R.A., Tamada K., Strome S.E., Chen L. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J. Immunol. 169:2002;4230-4236
78. Wilcox R.A., Chapoval A.I., Gorski K.S., Otsuji M., Shin T., Flies D.B., et al. Cutting edge: expression of functional CD137 receptor by dendritic cells. J. Immunol. 168:2002;4262-4267
79. Pauly S., Broll K., Wittmann M., Giegerich G., Schwarz H. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers. J. Leukoc. Biol. 72:2002;35-42
80. Goodwin R.G., Din W.S., Davis-Smith T., Anderson D.M., Gimpel S.D., Sato T.A., et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23:1993;2631-2641
81. Zhu G., Flies D.B., Tamada K., Sun Y., Rodriguez M., Fu Y.X., et al. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha-transgenic mice. J. Immunol. 167:2001;2671-2676
82. Bukczynski J., Wen T., Watts T.H. Costimulation of human CD28-T cells by 4-1BB ligand. Eur. J. Immunol. 33:2003;446-454
83. Cannons J.L., Lau P., Ghumman B., DeBenedette M.A., Yagita H., Okumura K., et al. 4-1BBL induces cell division, sustains survival and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:2001;1313-1324
84. Gramaglia I., Cooper D., Miner K.T., Kwon B.S., Croft M. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur. J. Immunol. 30:2000;392-402
85. Chu N.R., DeBenedette M.A., Stiernholm B.J., Barber B.H., Watts T.H. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28-T cells. J. Immunol. 158:1997;3081-3089
86. Cooper D., Bansal-Pakala P., Croft M. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 32:2002;521-529
87. Shuford W.W., Klussman K., Tritchler D.D., Loo D.T., Chalupny J., Siadak A.W., et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:1997;47-55
88. Takahashi C., Mittler R.S., Vella A.T. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162:1999;5037-5040
89. Taraban V.Y., Rowley T.F., O'Brien L., Chan H.T., Haswell L.E., Green M.H., et al. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur. J. Immunol. 32:2002;3617-3627
90. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell Biol. 18:1998;558-565
91. Lee H.W., Park S.J., Choi B.K., Kim H.H., Nam K.O., Kwon B.S. 4-1BB promotes the survival of CD8(+) T lymphocytes by increasing expression of Bcl-x(L) and Bfl-1. J. Immunol. 169:2002;4882-4888
92. Cannons J.L., Hoeflich K.P., Woodgett J.R., Watts T.H. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB. J. Immunol. 163:1999;2990-2998
93. Cannons J.L., Choi Y., Watts T.H. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J. Immunol. 165:2000;6193-6204
94. Tan J.T., Whitmire J.K., Murali-Krishna K., Ahmed R., Altman J.D., Mittler R.S., et al. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164:2000;2320-2325
95. Kwon B.S., Hurtado J.C., Lee Z.H., Kwack K.B., Seo S.K., Choi B.K., et al. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168:2002;5483-5490
96. Seo S.K., Park H.Y., Choi J.H., Kim W.Y., Kim Y.H., Jung H.W., et al. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J. Immunol. 171:2003;576-583
97. Weinberg A.D., Vella A.T., Croft M. OX40: life beyond the effector T cell stage. Sem. Immunol. 10:1998;471-480
98. Walker L.S., Gulbranson-Judge A., Flynn S., Brocker T., Lane P.J. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol. Today. 21:2000;333-337
99. Gramaglia I., Weinberg A.D., Lemon M., Croft M. OX40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:1998;6510-6517
100. Gramaglia I., Jember A., Pippig S.D., Weinberg A.D., Killeen N., Croft M. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:2000;3043-3050
101. Rogers P.R., Song J., Gramaglia I., Killeen N., Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 15:2001;445-455
102. Maxwell J.R., Weinberg A., Prell R.A., Vella A.T. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:2000;107-112
103. Prell R.A., Evans D.E., Thalhofer C., Shi T., Funatake C., Weinberg A.D. OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent. J. Immunol. 171:2003;5997-6005
104. Weinberg A.D. OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines. Trends Immunol. 23:2002;102-109
105. Stuber E., Neurath M., Calderhead D., Fell H.P., Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 2:1995;507-521
106. Imura A., Hori T., Imada K., Ishikawa T., Tanaka Y., Maeda M., et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183:1996;2185-2195
107. Kotani A., Hori T., Matsumura Y., Uchiyama T. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5. Immunol. Lett. 84:2002;1-7
108. Brocker T., Gulbranson-Judge A., Flynn S., Riedinger M., Raykundalia C., Lane P. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29:1999;1610-1616
109. Stuber E., Buschenfeld A., Luttges J., Von Freier A., Arendt T., Folsch U.R. The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis). Eur. J. Clin. Invest. 30:2000;594-599
110. Kim M.Y., Gaspal F.M., Wiggett H.E., McConnell F.M., Gulbranson-Judge A., Raykundalia C., et al. CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity. 18:2003;643-654
111. Chen A.I., McAdam A.J., Buhlmann J.E., Scott S., Lupher M.L. Jr., Greenfield E.A., et al. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity. 11:1999;689-698
112. Kopf M., Ruedl C., Schmitz N., Gallimore A., Lefrang K., Ecabert B., et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity. 11:1999;699-708
113. Pippig S.D., Pena-Rossi C., Long J., Godfrey W.R., Fowell D.J., Reiner S.L., et al. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:1999;6520-6529
114. Humphreys I.R., Walzl G., Edwards L., Rae A., Hill S., Hussell T. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 198:2003;1237-1242
115. Stuber E., Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:1996;979-989
116. Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J. Exp. Med. 191:2000;201-206
117. Linton P.J., Bautista B., Biederman E., Bradley E.S., Harbertson J., Kondrack R.M., et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 197:2003;875-883
118. Fillatreau S., Gray D. T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation. J. Exp. Med. 197:2003;195-206
119. Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.L., et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:1998;21-30
120. Zhai Y., Guo R., Hsu T.L., Yu G.L., Ni J., Kwon B.S., et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102:1998;1142-1151
121. Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.F., et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164:2000;4105-4110
122. Harrop J.A., Reddy M., Dede K., Brigham-Burke M., Lyn S., Tan K.B., et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 161:1998;1786-1794
123. Kwon B.S., Tan K.B., Ni J., Oh K.O., Lee Z.H., Kim K.K., et al. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272:1997;14272-14276
124. Morel Y., Truneh A., Sweet R.W., Olive D., Costello R.T. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167:2001;2479-2486
125. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274:1999;13733-13736
126. Shi C.S., Kehrl J.H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278:2003;15429-15434
127. Liu J., Schmidt C.S., Zhao F., Okragly A.J., Glasebrook A., Fox N., et al. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int. Immunol. 15:2003;861-870
128. Ye Q., Fraser C.C., Gao W., Wang L., Busfield S.J., Wang C., et al. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195:2002;795-800
129. Wong P., Pamer E.G. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166:2001;5864-5868
130. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:2001;423-429
131. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:2001;415-422